Comparative safety of generic versus brand calcineurin inhibitors in solid organ transplant patients: A systematic review and meta-analysis
- 10 February 2023
- journal article
- review article
- Published by Elsevier in Journal of the American Pharmacists Association
- Vol. 63 (3) , 709-719
Abstract
No abstract availableKeywords
Funding Information
- Auburn University
This publication has 51 references indexed in Scilit:
- Equivalence and interchangeability of narrow therapeutic index drugs in organ transplantationEuropean Journal of Hospital Pharmacy, 2013
- Safety and Efficacy of Generic Cyclosporine Arpimune in Filipino Low-Risk Primary Kidney Transplant RecipientsTransplantation Proceedings, 2012
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011
- Comparative Performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study Equations for Estimating GFR Levels Above 60 mL/min/1.73 m2American Journal of Kidney Diseases, 2010
- Interchangeability of ciclosporin formulations in stable adult renal transplant recipients: comparison of Equoral and Neoral capsules in an international, multicenter, randomized, open-label trialKidney International, 2010
- Calcineurin Inhibitor NephrotoxicityClinical Journal of the American Society of Nephrology, 2009
- Methodology for Dealing With Duplicate Study Effects in a Meta-AnalysisOrganizational Research Methods, 2007
- Clinical evaluation of efficacy and safety of cyclosporine (Imusporin) in renal transplant patients with stable graft function maintained on neoral or bioralIndian Journal of Urology, 2007
- The clinical impact of 1:1 conversion from Neoral to a generic cyclosporine (Gengraf) in renal transplant recipients with stable graft functionClinical Transplantation, 2006
- Switchover to generic cyclosporine in stable renal transplant recipients: A single unit experienceNephrology, 2004